Loading...
XSHE
301122
, Last price  
Name

Caina Technology Co Ltd

Chart & performance

D1W1MN
XSHE:301122 chart
P/E
—
P/S
—
EPS
0.05
Vol. 1Y
—
Shs. 5Y
5.89%
Rev. 5Y
-4.30%
Div Yld LY
—
Div Yld TTM
—
Revenues
355m
-8.50%
93,015,576143,377,356181,312,619505,006,042442,051,932442,051,932465,485,537465,485,536410,470,638387,893,050354,915,953
Net income
6m
-89.41%
12,588,35220,498,28132,333,112137,031,338130,681,695130,681,698161,868,649161,868,650112,564,14253,093,7665,620,712
CFO
28m
-73.28%
407,94621,334,30157,710,121170,023,815160,053,823138,881,98587,047,611105,443,58428,174,134
Dividend
Jun 09, 20260.04 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Caina Technology Co., Ltd. is dedicated to the research, development, manufacturing, and distribution of a variety of medical devices, particularly those related to injections and fluid delivery. The company's product portfolio includes essential sterile and single-use items such as safe, self-destructing syringes, disposable insulin syringes, and sterile insulin pen needles. They also provide sterile needles for blood collection and other specialized sterile medical instruments. Established in 2004, Caina Technology operates from its base in Jiangyin, China.
IPO date
Jan 26, 2022
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT